Method for treating hyperuricemia employing an sglt2...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7004 (2006.01) A61K 31/351 (2006.01) A61P 19/06 (2006.01)

Patent

CA 2725047

Methods are provided for treating hyperuricemia, employing an SGLT2 inhibitor alone, or in combination with a supply of carbohydrate, and/or in combination with an inhibitor of uric acid synthesis. Additionally, pharmaceutical compositions comprising an SGLT2 inhibitor with a supply of carbohydrate or an inhibitor of uric acid synthesis or a supply of carbohydrate and an inhibitor of uric acid synthesis are provided in the instant invention and are provided for use in the inventive methods.

L'invention porte sur des procédés de traitement de l'hyperuricémie, à l'aide d'un inhibiteur de SGLT2, seul ou en combinaison avec une alimentation en glucide, et/ou en combinaison avec un inhibiteur de la synthèse de l'acide urique. De plus, la présente invention porte sur des compositions comprenant un inhibiteur de SGLT2, avec une alimentation en glucide, ou un inhibiteur de synthèse de l'acide urique ou une combinaison d'un inhibiteur de SGLT2 et d'un inhibiteur de synthèse de l'acide urique, et sur l'utilisation de la présente invention dans des procédés novateurs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method for treating hyperuricemia employing an sglt2... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating hyperuricemia employing an sglt2..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating hyperuricemia employing an sglt2... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1505009

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.